Clinical Trial Update: A Multi-centre Chart Review Study of Stage I-III Non-Small Cell Lung Cancer in China

View source ↗

Summary

This clinical trial update describes a planned multi-centre chart review study of stage I-III non-small cell lung cancer in China; recruitment has not started y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: AstraZeneca | Conditions: Non-Small-Cell Lung | Status: NOT_YET_RECRUITING